XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
Discontinued Operations - Schedule of Amounts Included in Discontinued Operations (Details) - USD ($)
 3 Months Ended 12 Months Ended
Nov. 22, 2022
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Earnings (loss) from discontinued operations, net of tax                   $ (4,100,000) $ 202,800,000 $ 291,400,000
Gain on disposition of discontinued operations, net of tax                   19,900,000 3,356,300,000 55,900,000
Net earnings from discontinued operations   $ 11,500,000 $ 1,600,000 $ 3,900,000 $ (1,200,000) $ 1,681,100,000 $ 50,100,000 $ 43,800,000 $ 1,784,100,000 15,800,000 3,559,100,000 347,300,000
Held-for-sale or Disposed of by Sale | TransCore Holdings Inc, Zetec, and Civco Radiotherapy                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Net revenues                     100,400,000 638,000,000.0
Cost of sales                     71,200,000 372,900,000
Gross profit                     29,200,000 265,100,000
Selling, general and administrative expenses                     19,900,000 124,000,000.0
Income from operations                     9,300,000 141,100,000
Other income, net                     100,000 1,500,000
Earnings before income taxes                     9,400,000 142,600,000
Income taxes                     (6,200,000) 28,500,000
Earnings (loss) from discontinued operations, net of tax                     15,600,000 114,100,000
Gain on disposition of discontinued operations, net of tax                     1,717,500,000 55,900,000
Net earnings from discontinued operations                     1,733,100,000 170,000,000.0
Stock-based compensation expense                     4,500,000 900,000
Depreciation and amortization                     0 5,200,000
Held-for-sale or Disposed of by Sale | TransCore Holdings Inc, Zetec, and Civco Radiotherapy | Selling, general and administrative expenses                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Stock-based compensation expense                     900,000 5,400,000
Held-for-sale or Disposed of by Sale | Indicor                        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]                        
Net revenues                   0 916,100,000 944,000,000.0
Cost of sales                   0 432,100,000 434,200,000
Gross profit                   0 484,000,000.0 509,800,000
Selling, general and administrative expenses                   2,300,000 250,500,000 265,700,000
Impairment of intangible assets                   0 0 5,100,000
Income from operations                   (2,300,000) 233,500,000 239,000,000.0
Other income, net                   0 (700,000) 100,000
Earnings before income taxes $ 2,046,000,000                 (2,300,000) 232,800,000 239,100,000
Income taxes $ 407,200,000                 1,800,000 45,600,000 61,800,000
Earnings (loss) from discontinued operations, net of tax                   (4,100,000) 187,200,000 177,300,000
Gain on disposition of discontinued operations, net of tax                   19,900,000 1,638,800,000 0
Net earnings from discontinued operations                   $ 15,800,000 1,826,000,000 177,300,000
Stock-based compensation expense                     10,300,000 13,100,000
Depreciation and amortization                     $ 6,400,000 $ 18,200,000